A Study of HY-0102 in Patients With Advanced Solid Tumors

Clinical trial NCT06094777 · UNKNOWN

Trial details

NCT number: NCT06094777
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-12-18
Primary completion: 2025-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.